Gain Therapeutics Inc (GANX)
3.15
-0.24
(-7.08%)
USD |
NASDAQ |
Apr 24, 16:00
3.15
0.00 (0.00%)
After-Hours: 20:00
Gain Therapeutics Market Cap: 51.09M for April 24, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 23, 2024 | 54.98M |
| April 22, 2024 | 51.42M |
| April 19, 2024 | 51.58M |
| April 18, 2024 | 51.09M |
| April 17, 2024 | 51.58M |
| April 16, 2024 | 51.25M |
| April 15, 2024 | 50.12M |
| April 12, 2024 | 51.09M |
| April 11, 2024 | 54.50M |
| April 10, 2024 | 54.17M |
| April 09, 2024 | 54.82M |
| April 08, 2024 | 55.63M |
| April 05, 2024 | 57.74M |
| April 04, 2024 | 58.07M |
| April 03, 2024 | 64.72M |
| April 02, 2024 | 63.09M |
| April 01, 2024 | 62.12M |
| March 28, 2024 | 61.15M |
| March 27, 2024 | 60.50M |
| March 26, 2024 | 61.63M |
| March 25, 2024 | 59.20M |
| March 22, 2024 | 65.85M |
| March 21, 2024 | 70.88M |
| March 20, 2024 | 69.10M |
| March 19, 2024 | 68.93M |
| Date | Value |
|---|---|
| March 18, 2024 | 70.72M |
| March 15, 2024 | 69.58M |
| March 14, 2024 | 69.42M |
| March 13, 2024 | 73.64M |
| March 12, 2024 | 73.96M |
| March 11, 2024 | 75.75M |
| March 08, 2024 | 76.72M |
| March 07, 2024 | 74.61M |
| March 06, 2024 | 76.39M |
| March 05, 2024 | 75.58M |
| March 04, 2024 | 76.56M |
| March 01, 2024 | 75.91M |
| February 29, 2024 | 72.83M |
| February 28, 2024 | 72.28M |
| February 27, 2024 | 75.04M |
| February 26, 2024 | 72.93M |
| February 23, 2024 | 73.74M |
| February 22, 2024 | 71.96M |
| February 21, 2024 | 71.63M |
| February 20, 2024 | 75.69M |
| February 16, 2024 | 78.12M |
| February 15, 2024 | 77.79M |
| February 14, 2024 | 76.66M |
| February 13, 2024 | 73.09M |
| February 12, 2024 | 77.47M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
26.72M
Minimum
Nov 21 2023
187.65M
Maximum
Apr 05 2021
63.58M
Average
51.58M
Median
Apr 17 2024
Market Cap Benchmarks
| Eli Lilly and Co | 695.85B |
| Alpine Immune Sciences Inc | 4.232B |
| Outlook Therapeutics Inc | 177.42M |
| Greenwich LifeSciences Inc | 160.34M |
| CEL-SCI Corp | 78.00M |
Market Cap Related Metrics
| PEG Ratio | -0.0595 |
| Price to Book Value | 4.062 |
| Price | 3.15 |
| Earnings Yield | -54.29% |
| PEGY Ratio | -0.0595 |